Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07029698

A Study to See if a Combination of Vitamins That is Injected Into a Muscle is as Good and Safe as a Vitamin That is Taken by Mouth

Efficacy and Safety of a Parenterally Administered Fixed Vitamin Combination (Vitamin B6, B12 and Folic Acid) On Vitamin B12 Status and Methylation Capacity in Cobalamin Deficiency Compared to Oral Vitamin B12 Supplementation

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
46 (estimated)
Sponsor
Medice Arzneimittel Pütter GmbH & Co KG · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Primary efficacy objective: To investigate the effects of a parenterally vitamin B12 combination treatment versus an oral vitamin B12 mono therapy on the vitamin B12 status in female and male patients as determined by the change from baseline in serum vitamin B12 concentration after 4 weeks (28 days) of treatment. Secondary efficacy objectives: To evaluate the effects of a parenterally vitamin B12 combination versus an oral vitamin B12 mono therapy after 4 weeks of treatment on: * Serum holotranscobalamin * Serum homocysteine * Serum methylmalonic acid * Combined vitamin B12 markers (cB12) * Serum folic acid * Serum vitamin B6 * Serum S-adenosylmethione (SAM) * Serum S-adenosylhomocysteine (SAH) * SAM/SAH ratio * WHO-5 Well-Being Index * Medical Outcomes Study Questionnaire Short Form 36 Health Survey (SF-36) * Visual analogue scale (VAS) EQ-5D. Safety objectives: To evaluate the safety and tolerability of oral vitamin B12 mono therapy versus intramuscular vitamin B12 combination.

Conditions

Interventions

TypeNameDescription
DRUGVitamin B12, Vitamin B6, Folic acidA solution for intramuscular injection of fixed vitamin combination (5 mg vitamin B6, 1 mg B12 and 1,05 mg folic acid )
DRUGVitamin B12 (Cyanocobalamin)oral tablets of 1mg Vitamin B12

Timeline

Start date
2025-04-16
Primary completion
2025-12-01
Completion
2026-12-01
First posted
2025-06-19
Last updated
2025-06-19

Locations

2 sites across 1 country: Ukraine

Source: ClinicalTrials.gov record NCT07029698. Inclusion in this directory is not an endorsement.